Andes Biotechnologies Global andesbio.com


Public lists: Cancer Therapeutics (1136)

Andes Biotechnologies is a nucleic acid-based drug discovery and Development Company focused on solid tumor cancers. The company has discovered two novel families of long noncoding RNAs: sense (S-RNA) and antisense noncoding (AS-RNA). Both are present in all human cells, are synthesized in the mitochondria and migrate to the nucleus. The proprietary technology developed by Andes Biotechnologies is based on oligonucleotide therapeutics that target the novel long noncoding regulatory RNA that is ...Show all

Andes Biotechnologies is a nucleic acid-based drug discovery and Development Company focused on solid tumor cancers. The company has discovered two novel families of long noncoding RNAs: sense (S-RNA) and antisense noncoding (AS-RNA). Both are presen...Show all

Company (Alive / Active)

Phone: +56 22 367 2000

Fax:

Parque Tecnológico Zañartu
Av. Zañartu 1482, Ñuñoa
Santiago,
Chile

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Andes Biotechnologies Global $2.2M Dec 15, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Andes Biotechnologies Global Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein Apr 26, 2016 Feb 27, 2018 Patent